Wednesday, 8 December, 2021
Home Tags Pharmaceutical companies

Tag: Pharmaceutical companies

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.
Representative image | Pexels

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.
Dr Sharvil Patel, the managing director of Zydus Group | Photo by special arrangement

ZyCoV-D, the made-in-India Covid vaccine by Zydus Cadila, likely to hit markets in June

The Ahmedabad-based pharmaceutical firm plans to begin with manufacturing one crore doses a month. The vaccine is also being tested on adolescents.

Delhi HC asks govt to reply to PIL seeking firms to sell Remdesivir in domestic market

The plea claimed that there are more than 25 companies in India which manufacture the medicine, but only 6 to 8 are permitted to sell it in the domestic market.
Representational image | Pexels

Pharma industry warns of Covid drug shortages as raw materials prices surge 200%

Pharma firms say suspension of cargo from China has resulted hoarding, driving up prices of raw materials, seek govt intervention immediately.
Representational image | Remdesivir was developed by biopharmaceutical company Gilead Sciences | Gilead Sciences website

After govt move to review remdesivir MRP, pharma firms say will cut it to under Rs 3,500/vial

Remdesivir is one of the most sought-after experimental drugs for the treatment of Covid patients and part of the country’s treatment protocol.
Medicines | Representational image | Pexels

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.
Representational image | Pixabay

Why there’s no stopping the spectacular rise of this Indian pharma company

The optimism is stemming from the company’s capacity-expansion plans and potential to win more business as India cuts its reliance on Chinese suppliers.
A cyclist wearing a protective mask rides past a banner of Chinese president Xi Jinping in Shanghai | Qilai Shen/Bloomberg

Pharma companies to cut prices of news drugs by 51% to access Chinese market

Patients will only need to pay a small fraction of the cost of these drugs as the lion’s share of the bill will be footed by China’s $373 billion national medical insurance fund.

High demand, strict inspections — how Biden’s presidency could impact India’s pharma sector

US is the biggest market for Indian pharmaceutical companies and Biden's presidency is expected to bring with it some favourbable changes that could have a long-ranging impact.
×